NCCN Guidelines® Updates: Management of Prostate Cancer
Clinicians need up-to-date information on the role of germline and tumor genetic testing for risk stratification of men with localized prostate cancer so that men with indolent disease, unlikely to affect the patients in their lifetime, can be encouraged to pursue active surveillance and avoid treatment and side effects.
Category
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Updates: Breast Cancer - Treatment of HR-Positive, HER-Negative Early Stage Breast Cancer
Surgical management of the axilla and adjuvant systemic therapy strategies have evolved considerably.  A recent survey revealed substantial variation in surgeon management suggesting the potential for overtreatment of many patients and the need for education in this area. 
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Utility of Multigene Assays in Management of Early Stage Breast Cancer
Incorporating appropriate assays along with the traditional biomarkers in clinical decision-making still remains a challenge as all available tools have advantages and limitations that the clinicians should understand and explain to patients.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
NCCN Guidelines® Insights - Ovarian Cancer, Version 1.2019
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the United States, with less than half of patients living .5 years from diagnosis. A major challenge in treating ovarian cancer is that most patients have advanced disease at initial diagnosis.
Category
  • Ovarian Cancer
Format
  • Monograph/Journal Supplement
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
PARP Inhibitors in Breast Cancer: Expert Perspectives on Clinical Application and Genetic Testing
The goal of this activity is to improve participants’ knowledge of, confidence in, and competence in integrating PARP inhibitors into treatment of patients with breast cancer.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Prostate Cancer
During this tumor board, faculty will discuss the emerging role of tumor and germline genetic testing and the treatment of advanced disease.
Category
  • Prostate Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Recorded Presentations from the NCCN 2019 Nursing Program: Advancing Oncology Nursing™
The NCCN 2019 Nursing Program is designed to provide oncology nurses with current and relevant information related to the management of patients with cancer, including the effects cancer-related therapy can have on morbidity and mortality, and the quality of life of patients with cancer. 
Category
  • Palliative Care
Format
  • Recorded Webcast
Credits
Management of Lymphedema after Breast Cancer Treatment
Clinicians who work with breast cancer survivors need to be informed about the prevalence of and risk factors for lymphedema, its negative impact, and current management recommendations so that all survivors with lymphedema receive optimal treatment.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Evidence-Based Integrative Therapies in Breast Cancer
Clinician education on the topic of integrative therapies can help patients be informed enough to make the best decisions regarding non-conventional and conventional therapies to optimize their oncologic outcomes and quality of life.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Clinical Updates: Primary Therapy of Multiple Myeloma
It is important to help clinicians to keep up-to-date with the newer treatment options available to help select the most efficient treatment strategy. In addition, knowledge of the relevant side effects of the novel drugs reported in pivotal clinical studies and strategies for their prevention and management is also equally important to improve overall patient outcomes.
Category
  • Multiple Myeloma
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation

Pages